Down Syndrome Global Clinical Trials Review, H2, 2017

2017-07-26
Price :
Published : Jul-2017
No. of Pages : 78

Down Syndrome Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Down Syndrome Global Clinical Trials Review, H2, 2017” provides an overview of Down Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Down Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Insys Therapeutics Inc (INSY) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems. The company's flagship product, Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients. Its lead product candidate Syndros (dronabinol oral solution) is intendedfor the treatment of chemotherapy-induced nausea and vomiting (CINV) and anorexia associated with weight loss in patients with AIDS. Insys uses its proprietary sublingual spray technology to develop its products. The company offers its products to oncologists, pain specialists and supportive care centers. It has operations in the US and offers its products through third party agreements in international markets. Insys is headquartere......
$250

Cognition Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Cognition Therapeutics Inc (CogRx) is a drug discovery and development company that discovers and develops small molecule therapeutics. The company uses its proprietary biology and chemistry platforms for the development of novel drug targets and disease modifying therapies for the treatment of central nervous system disorders. Its products target the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and can efficiently displace toxic beta amyloid oligomers bound to receptor proteins on brain cells. The company uses screening strategies to identify small molecules capable of blocking the central toxicity of soluble oligomeric proteins. It also conducts clinical trials. CogRx is headquartered in Pittsburgh, Pennsylvania, the US. Cognition Ther......
$250

Oncolys BioPharma Inc (4588) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Oncolys BioPharma Inc (Oncolys) is a biotechnology company that discovers, and develops treatments for cancer and infectious diseases. The company imports and exports oncolytic viruses, drugs and medicines, and tumor diagnostic agents. Its pharmaceutical pipeline products include OBP-301, OBP-801, OBP-601, OBP-AI-001 and OBP-AI-002. Oncolys offers diagnostic pipeline such as OBP-401 and OBP-1101. Oncolys research and develops oncolytic virus drugs for infectious diseases, molecular targeted anti-cancer drugs and tumor diagnostic agents. The company also provides consulting services for development of biotechnology drugs. It operates through its offices located in Tokyo, Kobe and Okayama. Oncolys is headquartered in Tokyo, Japan. Oncolys BioPharma Inc (4588) - Pharmaceuticals ......
$250

Panacea Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Panacea Pharmaceuticals Inc (Panacea) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutic and diagnostic products for the treatment of cancer and central nervous system diseases. The company's pipeline products include PAN-301-1, a human aspartyl (asparaginyl) ß-hydroxylase (HAAH) nanoparticle therapeutic vaccine for the treatment of prostate cancer. Panacea also develops preclinical products in serodiagnosis of cancer, monoclonal antibody-based immunotherapy of cancer, immuno-imaging of cancer, and prevention of chemotherapy-induced cognitive impairment and peripheral neuropathy. Panacea is headquartered in Gaithersburg, Maryland, the US. Panacea Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profil......
$250

City of Hope – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary City of Hope (COH) is a biomedical research organization that offers cancers, diabetes and infectious diseases treatment services. The organization offers services in the fields of anesthesiology, interventional radiology, surgery, donor matching and marrow transplants, rehabilitation services and pathology, among others. It conducts research and development to develop treatments for cancer fighting drugs, avastin, herceptin, and rituxan. COH also offers educational services for post doctoral fellowships through its affiliates. The organization also provides clinical trial services. Its community practice site includes Arcadia, Corona, Mission Hills, Arcadia Radiation Oncology, Santa Clarita, Palm Springs, Simi Valley, Colton, Glendora, Pasadena, and others. The orgaization oper......
$250

2020 GeneSystems Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary 20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company that develops and commercializes diagnostic tests and proteomics products for early disease detection, therapy selection and biodefense applications. The company provides tests in the areas such as personalized medicine, early detection of lung cancer, and biological detection. 20/20 Gene's blood test technology is used in the early detection of lung cancer and provides method for analysis of cell signaling in tissue and technologies to detect biological toxins. It offers its products and services to drug companies, biodefense specialists and life scientists for protein analysis. 20/20 Gene is headquartered in Rockville, Maryland, the US. 2020 GeneSystems Inc - Pharmaceuticals & Healthcare - Deals and Alliance......
$250

Lepu Medical Technology (Beijing) Co Ltd (300003) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical device company that designs, develops, and distributes medical equipments. The company's products include interventional cardiology products, cardiac in vitro diagnosis products, occlusion devices, pacemaker, angiographic equipment, prosthetic heart valves, and anesthetic products. Its interventional cardiology products include stent, catheter, balloon, guidewire and accessories. Lepu Medical's anesthetic products comprise disposable blood pressure transducer, disposable central venous catheter kit, antimicrobial central venous catheter, and needle-free connector. The company also offers interventional angiography systems, surgical staplers; and neurological intervention products such as microcatheters, disposa......
$250

GRI Bio Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary GRI Bio Inc (GRI Bio) is a biotech company that develops and manufactures therapies for inflammatory diseases. The company develops Natural Killer T cell based therapies for the treatment of liver disease and autoimmune disoders. Its lead candidate GRI-0621, a novel oral therapeutic for liver disease is an inhibitor of type I NKT cells. GRI Bio's other pipeline products include GRI 101, GRI-0621, GRI 201, GRI 202 and GRI 203 are under preclinical stage of development for the treatment of chronic liver disease and ALD. Its research and development facility is located at the Torrey Pines Institute of Molecular Studies. GRI Bio is headquartered in La Jolla, California, the US. GRI Bio Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive dat......
$250

Particle Sciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Particle Sciences Inc (Particle Sciences), a subsidiary of The Lubrizol Corp is a contract research organization that offers complete formulation, analytic, bioanalytic and clinical trial material manufacturing solutions. The organization concentrates on BCS II/III/IV molecules, biologics and highly potent compounds through a variety of technologies including gels, emulsions, drug or device combination products, micro and nano-particulates, and solid solutions, among others. Particle Sciences serves clients including privately-backed start-ups, foundations, governments, universities, hospitals and pharmaceutical and biotech companies. The organization also has proprietary drug delivery platforms for the preformulation and formulation of drugs as well as technology platform for d......
$250

Pharmaceutical Product Development LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Pharmaceutical Product Development LLC (PPD) is a contract research organization (CRO), which offers drug discovery, development and lifecycle management services. The company's service portfolio encompasses early development clinical trial services, drug research and development, regulatory support and late-stage clinical trial management, among others. It has expertise in clinical trials in therapy areas including cardiovascular system, central nervous system, dermatology, gastroenterology, hematology, cancer, infectious diseases, ophthalmology, respiratory and endocrine systems, metabolism, rare diseases and urology. PPD's clients include pharmaceutical, biotechnology, medical device, and academic and government organizations. The company has a presence in North America, Sout......
$250